CardioComm Solutions, Inc

CardioComm Press Releases
 
  Previous Page previous page
About CardioComm
 

Letter from the CEO, December 19, 2013

Dear Shareholders,

This is a special CEO update to provide news related to our HeartCheck™ sales and marketing efforts. Please find attached a copy of a Letter of Intent (LOI) provided under the approval of McKesson Canada, Specialty Division (McKesson). The LOI is self-explanatory.

As stated by CardioComm Solutions over the past few months, we have been working diligently to place the HeartCheck™ PEN and the SMART Monitoring ECG service into pharmacies in Canada.  Pharmacies are a very appropriate setting for the recommended use of an ECG screening solution, performed by pharmacists, on persons who are at risk for arrhythmia based cardiac diseases.

In October we initiated an aggressive marketing campaign which began with the launch of a CBC circulated TV commercial and the placement of HeartCheck™ PEN devices into pharmacies in Southern Ontario under the Total Health and Remedy’sRx pharmacy banner groups. In November and December we have been scheduling the setup of the HeartCheck Partner Program in these pharmacies. While doing so, we have also continued to look at additional and larger pharmacy banner groups.

We view this LOI to be an important milestone in our efforts of expanding HeartCheck™ ECG screening and monitoring services into the consumer market.  We have worked hard to secure independent regulatory and clinical validation of our technologies, and are now focused on the sales and implementation of the HeartCheck™ PEN and SMART Monitoring ECG screening services into pharmacies and other verticals globally.

We are grateful to have been permitted to share this update with our shareholders. Details regarding the project will be disclosed at a later date and any press releases will be made in accordance with non-disclosure details that are currently in place.

More information regarding the HeartCheck™ products and SMART monitoring solutions is available at the Company’s website www.theheartcheck.com.

Forward-looking statements
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.







Investor Information

Previous Updates:
July 9 2013

I acknowledge that shareholders and interested parties wish to have news about HeartCheck™ PEN sales


December 11, 2012
November was a quiet month with respect to press releases from CardioComm Solutions (CCS); however, we’ve been very busy behind the scenes developing new channels for the promotion of our devices and software.


November 23, 2012
CardioComm Solutions, Inc. is pleased to confirm their participation in a BTV news release


November 1, 2012
The past few weeks have been very busy for CardioComm Solutions.


September 25, 2012
2012 North American Award for Enabling Technology for Cardiac Monitoring Technology


August 30, 2012
Heart and Stroke Foundation's Atrial Fibrillation screening booth set up at the Canadian National Exhibition


August 28, 2012
Invitations for HeartCheck™
PEN Device & Smart Monitoring Product Evaluation Starts this Week.



July 31, 2012
We are pleased to provide a preview of the new HeartCheck™ PEN product brochure that is now available on our website



June 27 2012
About WAISCO Inc from Medical
Coaches Incorporated




June 20 2012
"It’s been a busy two months for CardioComm Solutions, Inc."




April 30 2012
"CardioComm receives excellent initial response from Hospimedica International Advertising Campaign"



April 27 2012

CardioComm attends the World Congress of Cardiology Scientific Sessions in Dubai



May 8 2012

CardioComm Solutions Schedules Annual General Meeting (AGM) for June 27th, 2012



June 3 2013
Letter from the CEO


 


Investor Information


Etienne Grima
- MSc CHE
Chief Executive Officer

Anatoly Langer
MD, M.Sc, FRCPC, FACC
Chairman of the Board

William E. Smith
Board Member

Yury Levin

Board Member

David Newman
Board Member

Simi Grosman - MBA

Consultant & Board Member

Investor Information


Etienne Grima - MSc CHE
Chief Executive Officer

Wendy Hsieh
Chief Financial Officer

Wade Barnes
Chief Technology Officer

View more

 

Arrhythmia EKG Management | 12 Lead ECG Management | ECG Software | EKG Management | Web Based ECG | EKG Software